1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Vaxart Inc (VXRT)
  7. Quote


Vaxart Stock Price

-0.55 (-6.91%)
Upgrade to Real-Time
Regular Market
Volume 2,924,405
Bid Price 7.41
Ask Price 7.42
News (2)
Day High 8.00


52 Week Range


Day Low 7.36
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Vaxart Inc VXRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.55 -6.91% 7.41 11:35:54
Open Price Low Price High Price Close Price Prev Close
7.81 7.36 8.00 7.96
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
13,592 2,924,405 $ 7.65 $ 22,383,704 - 4.862 - 24.90
Last Trade Time Type Quantity Stock Price Currency
11:36:29 500 $ 7.41 USD


Draw Mode:

Vaxart Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 929.93M 125.50M 124.78M $ 4.05M $ - -0.35 -14.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 49.10k 2.30%

more financials information »

Vaxart News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VXRT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.708.136.567.585,766,5600.7110.6%
1 Month7.188.136.417.093,675,2890.233.2%
3 Months8.60559.406.417.353,547,696-1.20-13.89%
6 Months6.6210.336.418.016,854,3140.7911.93%
1 Year8.4624.904.8628.7211,182,204-1.05-12.41%
3 Years3.2424.900.25437.489,061,8214.17128.7%
5 Years15.288924.900.25437.465,622,629-7.88-51.53%

Vaxart Description

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.